Innovation Zed Announce Non-Invasive Continuous Glucose Monitoring Project and Appointment of a New Researcher
October 11, 2021 01:00 ET
|
Innovation Zed Ltd.
DUBLIN, Oct. 11, 2021 (GLOBE NEWSWIRE) -- Innovation Zed Ltd., developer of novel diabetes technologies (the InsulCheck range), announced further advancement in their research of technologies for...
Nemaura Medical Announces Commercial Agreement with UK Licensee
September 27, 2021 08:00 ET
|
Nemaura Medical, Inc
Nemaura has previously placed order for 200,000 CGMs in anticipation of commercial ramp-up Loughborough, England, Sept. 27, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura”...
Nemaura Medical to Present at the Benzinga Healthcare Small Cap Conference
September 21, 2021 08:30 ET
|
Nemaura Medical, Inc
Loughborough, England, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable...
Supersapiens Welcomes Seven-Time Grand Tour Winner Chris Froome as Newest Advisor and Investor
September 09, 2021 10:30 ET
|
Supersapiens
Atlanta, GA, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Supersapiens, the world’s imminent energy management system for performance athletes, powered by the Abbott Libre Sense Glucose Sport Biosensor, is...
Nemaura Medical Announces Presentation on its Licensed Why WAIT Program During the American Diabetes Association 81st Annual Scientific Sessions
June 30, 2021 09:15 ET
|
Nemaura Medical, Inc
Loughborough, England, June 30, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
Nemaura Medical to Present at the H.C. Wainwright Global Life Sciences Conference
March 02, 2021 08:00 ET
|
Nemaura Medical, Inc
Loughborough, England, March 02, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
Nemaura Medical Appoints Thomas Mortensen as Head of E.U. Commercial Operations and Marketing
February 04, 2021 08:30 ET
|
Nemaura Medical, Inc
Loughborough, England, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
Digital Diabetes Management Market revenue to cross USD 54 Bn by 2027: Global Market Insights, Inc.
January 25, 2021 05:00 ET
|
Global Market Insights, Inc
Selbyville, Delaware, Jan. 25, 2021 (GLOBE NEWSWIRE) -- According to latest report “Digital Diabetes Management Market by Product Type (Devices, , Services), Patient Type (Type 1, Type 2), End-Use...
Global Continuous Glucose Monitoring (CGM) Devices Market to Witness a CAGR of 12.4% during 2019-2025
May 02, 2019 06:34 ET
|
Energias Market Research
NEW YORK, May 02, 2019 (GLOBE NEWSWIRE) -- The global continuous glucose monitoring (CGM) devices market is expected to grow significantly from USD 529 million in 2018 to USD 1,263 million in 2025,...
T1D Exchange Teams with Tidepool to Leverage Device Data for Groundbreaking Study of Type 1 Diabetes
November 29, 2018 07:45 ET
|
T1D Exchange
BOSTON, Nov. 29, 2018 (GLOBE NEWSWIRE) -- T1D Exchange today announced a research partnership with Tidepool to better understand the link between patient reported experiences and the mild and...